Monex Group, Inc. (TYO:8698)

Revance Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	53,467	97,935	175,159	253,458	163,989
Short-Term Investments	376,787	404,602	863,834	843,590	774,582
Trading Asset Securities	1,406	443	20,964	23,178	16,524
Accounts Receivable	-	-	182,491	162,285	182,017
Other Receivables	43,908	47,870	85,206	91,376	42,774
Property, Plant & Equipment	5,155	6,579	6,043	6,564	4,961
Goodwill	20,020	13,581	19,786	18,589	17,223
Other Intangible Assets	15,221	16,659	27,132	26,761	27,638
Investments in Debt & Equity Securities	19,110	16,527	15,685	18,108	11,253
Other Current Assets	125,012	109,741	106,114	161,955	158,366
Long-Term Deferred Tax Assets	448	393	1,119	1,552	1,456
Other Long-Term Assets	49,107	47,312	577	345	347
Total Assets	709,641	761,642	1,504,110	1,607,761	1,401,130
Accounts Payable	-	-	33,949	29,004	37,637
Short-Term Debt	87,015	100,161	415,709	421,944	363,479
Other Current Liabilities	438,448	465,195	929,198	980,345	850,148
Long-Term Deferred Tax Liabilities	7,125	7,448	836	1,959	3,074
Other Long-Term Liabilities	49,175	47,900	22,348	63,981	49,696
Total Liabilities	583,387	628,519	1,403,356	1,501,743	1,310,605
Common Stock	13,144	13,144	13,144	13,144	10,394
Additional Paid-In Capital	51,285	41,193	41,027	41,174	40,253
Retained Earnings	46,266	62,131	34,509	39,268	30,148
Comprehensive Income & Other	14,012	15,417	11,675	11,083	9,224
Total Common Equity	123,984	131,712	99,641	104,286	89,573
Minority Interest	2,270	1,411	1,113	1,732	952
Shareholders' Equity	126,254	133,123	100,754	106,018	90,525
Total Liabilities & Equity	709,641	761,642	1,504,110	1,607,761	1,401,130
Total Debt	87,015	100,161	415,709	421,944	363,479
Net Cash (Debt)	344,645	402,819	644,248	698,282	591,616
Net Cash Growth	-14.44%	-37.48%	-7.74%	18.03%	7.30%
Net Cash Per Share	1346.20	1566.20	2440.17	2681.89	2300.56
Filing Date Shares Outstanding	251.15	257.56	256.37	266.27	257.64
Total Common Shares Outstanding	252.69	257.56	256.37	266.27	257.64
Working Capital	73,493	87,420	53,596	100,039	80,417
Book Value Per Share	490.65	511.38	388.67	391.66	347.67
Tangible Book Value	88,743	101,472	52,723	58,936	44,712
Tangible Book Value Per Share	351.19	393.97	205.66	221.34	173.54

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.